Evidence map›Paper›PMID 33091716›Full record

ArticleAddictive behaviors2021

Profiles of lifetime substance use are differentiated by substance of choice, affective motivations for use, and childhood maltreatment.

Naomi Sadeh, Rickie Miglin, Nadia Bounoua, Emil Beckford, Suzanne Estrada, Arielle Baskin-Sommers

Open access · greenAbstract read
In one paragraph

Article in Addictive behaviors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Divergent disinhibition profiles linked to externalizing psychopathology.Journal of psychopathology and clinical science · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Validation of theSubstance use & misuse · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Naomi SadehUniversity of Delaware, Department of Psychological and Brain Sciences, 105 The Green, Newark, DE 19716, United States. Electronic address: nsadeh@udel.edu.
Rickie MiglinUniversity of Delaware, Department of Psychological and Brain Sciences, 105 The Green, Newark, DE 19716, United States. Electronic address: rickiem@udel.edu.
Nadia BounouaUniversity of Delaware, Department of Psychological and Brain Sciences, 105 The Green, Newark, DE 19716, United States. Electronic address: nbounoua@udel.edu.
Emil BeckfordYale University, Department of Psychology, P.O. Box 208205, New Haven, CT 06520, United States. Electronic address: emil.beckford@bulldogs.yale.edu.
Suzanne EstradaYale University, Department of Psychology, P.O. Box 208205, New Haven, CT 06520, United States. Electronic address: suzanne.estrada@yale.edu.
Arielle Baskin-SommersYale University, Department of Psychology, P.O. Box 208205, New Haven, CT 06520, United States. Electronic address: arielle.baskin-sommers@yale.edu.
University of Delaware · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Updated confocal microscope in the Imaging Core facility to support biomedical researchP20GM103653 · NIGMS · DELAWARE STATE UNIVERSITY · PI HARRINGTON, MELISSA A · 2012 to 2022
$22.7M
Adaptive and Maladaptive Neural Network Responses to Inhibitory ChallengesR01MH116228 · NIMH · UNIVERSITY OF DELAWARE · PI SAMIMI-SADEH, NAOMI · 2019 to 2023
$2.9M
Multi-level analysis of affective inhibitory controlF31MH120936 · NIMH · UNIVERSITY OF DELAWARE · PI BOUNOUA, RABEA-NADIA · 2019 to 2021
$133k
NCATS NIH HHS UL1 TR001863NIGMS NIH HHS P20 GM103653NIMH NIH HHS F31 MH120936NIMH NIH HHS L30 MH117623NIMH NIH HHS R01 MH116228
6 · The paper itself

Abstract

To develop personalized interventions and improve outcomes in substance-using populations, research is needed on the heterogeneity in substance use patterns and motivations that exists among adult substance users. This study took a person-centered approach to identify profiles of lifetime substance use and discern the psychosocial differences among them. To survey a spectrum of drug use severity, 1106 adults (43.4% women) were recruited from forensic and community samples. Participants reported on the frequency of lifetime substance use across multiple drug categories (sedatives, stimulants, marijuana, heroin, hallucinogens, misuse of prescription drugs) and alcohol use. Latent profile analysis was used to identify distinct profiles of substance use that were then compared on potential risk and maintenance factors for substance use. Four profiles of lifetime substance use emerged that diverged on severity of use and degree of mono vs. polysubstance use (Recreational Marijuana Use, Heavy Multidrug Intoxication, Heavy Marijuana Use, and Heavy Opioid and Polysubstance Use). The profiles differed on affective motivations for substance use (e.g., using to cope vs. using to seek a thrill), age of use onset, drug-related functional impairment, and experiences of childhood maltreatment. Cognitive functioning did not differentiate the heavy substance use profiles. Results provide compelling initial evidence that lifetime patterns of use can be used to identify groups of substance users with distinct risk and maintenance factors. Results highlight affective motivations for substance use and maltreatment history as potential treatment targets and underscore the importance of studying polysubstance use in the context of the opioid epidemic.

Indexed as

Child AbuseDrug UsersSubstance-Related DisordersAdultAnalgesics, OpioidChildFemaleHumansMaleMotivationAnalgesics, OpioidAdultsCannabisChildhood maltreatmentOpioidsPolysubstance useTypologies

Identifiers

PMID33091716
PMCPMC8312989
OpenAlexW3092795518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.